ANZATAX 6MG-ML VIAL 6 concentrate for solution for injection 25ml Vial
Product Details
ANZATAX 6MG/ML concentrate for solution for injection 25ml Vial is a powerful antineoplastic agent used in the treatment of various types of cancer.
This medication, known generically as Paclitaxel, belongs to the taxane class of chemotherapy drugs, which are vital in slowing or stopping the growth of cancer cells.
Each 25ml vial contains a concentrated solution designed for intravenous administration by healthcare professionals.
It is primarily indicated for the management of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi's sarcoma.
Principle Ingredients
- Paclitaxel: 6 mg/ml
Benefits of Use
ANZATAX (Paclitaxel) works by disrupting the internal structure of cancer cells, preventing them from dividing and multiplying.
This action leads to the destruction of cancer cells and can significantly contribute to disease control and improved patient outcomes in sensitive cancers.
It is a cornerstone treatment in specific chemotherapy regimens, often used alone or in combination with other anti-cancer therapies.
How to Use
- ANZATAX is strictly for intravenous infusion and must be administered by a qualified healthcare professional in a clinical setting.
- The concentrate must be diluted before infusion, following specific guidelines provided by the manufacturer.
- Dosage and treatment schedule are highly individualized and determined by the treating physician based on the type of cancer, patient's body surface area, and response to treatment.
- Patients may receive premedication to reduce the risk of hypersensitivity reactions.
- Regular monitoring of blood counts and other vital signs will be performed during the treatment course.
Caution & Warnings
- Must be administered under the direct supervision of a physician experienced in chemotherapy.
- Risk of severe hypersensitivity reactions; premedication is often required.
- Bone marrow suppression (myelosuppression), leading to low white blood cell counts, red blood cell counts, and platelets, is a common and serious side effect.
- Peripheral neuropathy (nerve damage) may occur, manifesting as tingling, numbness, or pain in extremities.
- Cardiac abnormalities, including bradycardia and conduction delays, have been reported.
- Patients should avoid becoming pregnant during treatment and for a specified period after treatment completion due to potential fetal harm.
- Inform your doctor about all other medications, supplements, and herbal products you are using to avoid potential drug interactions.
- Report any unusual or severe side effects to your healthcare provider immediately.
| Gtin | 1301256585 |
|---|---|
| Recommended Sale Price | 636.95 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | PACLITAXEL |
| SFDA Reg. No | 1301256585 |
| IBC | 1301256585 |
| Drug Type | Prescription |
| Scientific Name | Paclitaxel |
| Strength | 6 |
| Strength Unit | mg/ml |
| Form | Concentrate for solution for injection |
| Admin Route | Intravenous Injection |
| Size | 25 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 25 ml |
| Refrigerator Storage | No |
